Abstract
Ibrexafungerp (BREXAFEMME(R)) is an orally active triterpenoid antifungal drug being developed by SCYNEXIS, Inc. for the treatment of fungal infection......
小提示:本篇文献需要登录阅读全文,点击跳转登录